The Kaplan‐Meier log‐rank survival curves demonstrated that the OS and DFS of all patients with breast cancer with high expression of FLI‐1 were significantly shorter than those in patients with low expression Median survival time (Figure 1C,D). This evidence concerns the gene FLI1 and breast cancer.